Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Harbour BioMed Reports Full Year 2023 Financial Results 2024-03-28 22:10
ZEISS Sets Stage for Future of Ophthalmic Surgery and 3D Visualization at ASCRS 2024 2024-03-28 21:00
Primech Holdings Limited Provides Financial Updates and Corporate Highlights For the Six Months Ended September 30, 2023 2024-03-28 20:30
GenFleet and BeiGene Enter into Trial Collaboration for a Potentially First-in-class Combination Therapy to Initiate Phase Ib/II Study of GFH009 (CDK9 inhibitor) and BRUKINSA® (zanubrutinib) Treating Diffuse Large B Cell Lymphoma 2024-03-28 19:00
Tigermed Reports Full Year 2023 Results 2024-03-28 18:31
Sirnaomics Announces 2023 Annual Results 2024-03-28 17:09
Vafseo® approved by the U.S. FDA for the treatment of anemia due to chronic kidney disease in dialysis-dependent adult patients 2024-03-28 15:00
TCI Gene Enhancing Malaysia's Preventive Healthcare In Collaboration With ALPRO Pharmacy 2024-03-28 12:30
XtalPi to Present the Latest Progress of Its AI Cancer Vaccine Design Platform at AACR 2024 2024-03-28 09:05
Everest Medicines Announces Financial Results for Full Year Ended December 31, 2023 2024-03-28 07:01
Ascentage Pharma Announces 2023 Annual Results 2024-03-27 22:30
CStone Pharmaceuticals Reports 2023 Annual Results and Business Updates 2024-03-27 22:00
CARsgen Announced 2023 Annual Results 2024-03-27 20:50
Sanyou Bio: Sanyou's Intelligence-Enabled Innovative Biologics R&D Platform Leads in the New Era of Biological Drug Development 2024-03-27 20:00
YolTech Therapeutics to Participate in 2024 Cell & Gene Meeting on the Mediterranean 2024-03-27 20:00
Recbio And Rongsheng Biotech Signed a Strategic Cooperation Agreement On The New Adjuvant Vaccine Project 2024-03-27 11:24
Innovative strides in medical-grade TPUs: ICP DAS-BMP to introduce groundbreaking solutions at CMEF and Medtec Japan 2024-03-27 09:20
Innovent Dosed First Participant in Phase 3 Clinical Study (Neoshot) of IBI310 (Anti-CTLA-4 Monoclonal Antibody) in Combination with Sintilimab for MSI-H/dMMR Colon Cancer Neoadjuvant Therapy 2024-03-27 08:00
Bridge Biotherapeutics Announces a Research Collaboration with the University of Colorado School of Medicine to Explore Potential of BBT-877 for Immuno-Oncology 2024-03-27 06:00
World First Use of Lightpoint's SENSEI® Drop-In Gamma Probe in Bladder Cancer Surgery Performed in Spain 2024-03-27 05:59
1 81 82 83 84 85 962